Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas
Open Access
- 1 August 1995
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 346 (8971) , 336-340
- https://doi.org/10.1016/s0140-6736(95)92225-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1994
- Treatment approaches to the low-grade lymphomasBlood, 1994
- Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportNew England Journal of Medicine, 1993
- Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factorBlood, 1993
- Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 PatientsAnnals of Internal Medicine, 1993
- Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.Journal of Clinical Oncology, 1990
- Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.Journal of Clinical Oncology, 1989
- Preliminary validation of the opposing view method for quantitative gamma camera imagingMedical Physics, 1989
- Regimen-related toxicity in patients undergoing bone marrow transplantation.Journal of Clinical Oncology, 1988
- Mechanical Ventilation after Marrow Transplantation: Risk Factors and Clinical OutcomeAmerican Review of Respiratory Disease, 1988